Literature DB >> 2149014

Ifosfamide and mesna with doxorubicin have activity in malignant mesothelioma.

A S Alberts, G Falkson, L van Zyl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2149014     DOI： 10.1016/0277-5379(90)90637-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma.

Authors:  Kageaki Watanabe; Yusuke Okuma; Shoko Kawai; Makoto Nagamata; Yukio Hosomi
Journal:  Thorac Cancer       Date:  2021-04-08       Impact factor: 3.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.